PO.TB10.15 · 肿瘤生物学

Mito-EV 驱动的线粒体转移:胶质母细胞瘤中铁死亡的触发因素

Mito-EV-driven mitochondrial transfer: A trigger for ferroptosis in glioblastoma

海报缩略图:Mito-EV 驱动的线粒体转移:胶质母细胞瘤中铁死亡的触发因素
编号 3342 展板 3 时间 4/20 02:00–05:00 区域 Section 26 主讲 Junbo Liao, MD;M Phil
分会场 Extracellular Vesicles and Long-Range Tumor-Host Communication
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Junbo Liao, Shuhan Cao, Ka Kit Gilberto Leung, Karrie. M Kiang

Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong

摘要 Abstract

中文摘要
背景:胶质母细胞瘤(GBM)是最具侵袭性的原发性脑肿瘤,由于其代谢适应性和对细胞死亡的抵抗性,治疗选择有限。铁死亡是一种依赖铁、涉及脂质过氧化的通路,为 GBM 提供了一个有前景的靶点。基于细胞外囊泡(EV)的线粒体转移使受损线粒体能够在细胞间穿梭,从而在癌症微环境中调节受体细胞的代谢。在脂肪细胞产热过程中,受损的线粒体会在肥胖等应激条件下以 Mito-EV 的形式释放。本研究探讨了来自应激脂肪细胞的 Mito-EV 介导的转移如何激活 GBM 细胞中的铁死亡。 方法:通过离心从脂肪细胞中分离含有应激线粒体的 Mito-EV,并通过显微镜和蛋白分析进行表征。将 GBM 细胞暴露于 Mito-EV 以进行线粒体转移,与游离线粒体进行比较,并通过成像加以确认。用激活剂诱导铁死亡,并通过细胞死亡和应激标志物进行评估。在体内实验中,将来自肥胖小鼠模型的循环 Mito-EV 单独或与铁死亡试剂一起注入 GBM 肿瘤模型,并通过成像和组织分析评估肿瘤反应。 结果:与游离线粒体相比,Mito-EV 转移增强了 GBM 细胞对线粒体的摄取,使其整合入网络并诱导氧化应激。这提高了铁死亡的敏感性,降低了对激活剂的需求,并改变了细胞死亡调控因子。在体内,Mito-EV 处理促进了铁死亡,且当与激活剂联合使用时,减少了肿瘤生长并显示出铁死亡证据,同时毒性较低。 结论:来自应激脂肪细胞的 Mito-EV 介导的线粒体转移通过氧化应激增强了 GBM 中的铁死亡,提出了一种利用循环 Mito-EV 在肥胖相关背景下发挥抗癌作用的新策略。
查看英文原文 English abstract
Background: Glioblastoma (GBM) is the most aggressive primary brain tumor, with limited therapeutic options due to metabolic adaptability and resistance to cell death. Ferroptosis, an iron-dependent pathway involving lipid peroxidation, offers a promising GBM target. Extracellular vesicle (EV)-based mitochondrial transfer enables intercellular shuttling of damaged mitochondria, modulating recipient cell metabolism in cancer microenvironments. During adipocyte thermogenesis, damaged mitochondria are released as Mito-EVs under stress conditions like obesity. This study explores how Mito-EV-mediated transfer from stressed adipocytes activates ferroptosis in GBM cells. Methods: Mito-EVs containing stressed mitochondria were isolated from adipocytes via centrifugation and characterized by microscopy and protein analysis. GBM cells were exposed to Mito-EVs for mitochondrial transfer, compared to free mitochondria, and confirmed by imaging. Ferroptosis was induced with activators and evaluated through cell death and stress markers. In vivo, circulating Mito-EVs from an obese mouse model were injected into GBM tumor models, alone or with ferroptosis agents, with tumor response assessed by imaging and tissue analysis. Results: Mito-EV transfer enhanced mitochondrial uptake in GBM cells over free mitochondria, integrating into networks and inducing oxidative stress. This increased ferroptosis sensitivity, with reduced activator requirements and altered cell death regulators. In vivo, Mito-EV treatment promoted ferroptosis and, when combined with activators, reduced tumor growth with ferroptosis evidence and low toxicity. Conclusions: Mito-EV-mediated mitochondrial transfer from stressed adipocytes boosts ferroptosis in GBM via oxidative stress, proposing a new strategy using circulating Mito-EVs for anticancer effects in obesity-linked contexts.
利益披露 Disclosure
J. Liao, None.. S. Cao, None.. K. Leung, None.. K. Kiang, None.

← 返回 AACR 2026 检索